These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. For research use only.  Legal & Disclaimer

GLP-1 Receptor Agonist · Research Compound

Semaglutide Research Compound

Synthetic GLP-1 receptor agonist analog — 34 amino acids with C18 fatty diacid chain. Third-party tested via Krause Analytical, reviewed by Sabrina Runbeck, PA-C. Available in five vial sizes for qualified researchers and laboratories.

5 Vial Sizes: 5mg–30mg
Krause Analytical COA
Sabrina Runbeck, PA-C
Finnrick Pulse Verified
≥99% Purity
Research Use Only — Not for Human Use

Sequence Labs semaglutide is a research material, not a medicine. It is a research-grade synthetic GLP-1 receptor agonist analog supplied exclusively for in vitro and preclinical laboratory research. It is not FDA-approved, not intended for human use, and is not interchangeable with any marketed pharmaceutical product. It must not be administered to any person.

Compound Identity

What Is Semaglutide?

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist analog composed of 34 amino acids. It was developed as a long-acting GLP-1 analog and has been widely studied in the peer-reviewed literature. Sequence Labs supplies a research-grade analog for laboratory use only — not a finished drug product and not for human use.

The compound's molecular architecture is derived from native GLP-1(7–37), a naturally occurring incretin hormone. Semaglutide differs from native GLP-1 through two key structural modifications: a substitution at position 8 (replacing alanine with Aib, α-aminoisobutyric acid) to resist DPP-4 enzymatic cleavage, and the attachment of a C18 fatty diacid chain via a linker at lysine-26. This acylation enables albumin binding in plasma, dramatically extending the compound's half-life from the minutes seen with native GLP-1 to approximately one week.

Molecular specifications: Semaglutide is a 34-amino-acid synthetic peptide (C₁₈₇H₂₉₁N₄₅O₅₉, MW ≈ 4,113.58 Da) featuring a C18 fatty diacid moiety attached via an OEG-OEG-gamma-Glu-mini-PEG linker at Lys²⁶. CAS: 910463-68-2.

  • Class: GLP-1 receptor agonist (GLP-1RA) — long-acting synthetic incretin analog
  • Origin: Developed by Novo Nordisk; structurally derived from human GLP-1(7–37)
  • Structural modification: Position-8 Aib substitution plus C18 fatty diacid chain for albumin binding
  • Sequence origin: 94% sequence homology to human GLP-1; altered at 2 positions relative to natural sequence
  • Research form: Supplied lyophilized (white to off-white powder) for research sample preparation

Published Research

Research Background

Semaglutide is among the most extensively studied GLP-1 receptor agonists in published scientific literature, with hundreds of peer-reviewed studies examining its receptor binding properties, incretin signaling mechanisms, and effects in various preclinical and in vitro models. The research interest spans multiple biological systems where GLP-1 receptors are expressed.

GLP-1 Receptor Binding
Published research has examined receptor binding kinetics, agonist potency, and G-protein coupling at the GLP-1R.
Incretin Signaling Pathways
Peer-reviewed studies have investigated cAMP second-messenger cascades and downstream signaling downstream of GLP-1R activation.
Pancreatic Beta-Cell Studies
Research has examined the role of GLP-1R agonism in pancreatic islet cell function and beta-cell proliferation models.
Gastric Motility Research
Published studies have investigated GLP-1R-mediated regulation of gastric emptying and gastrointestinal motility at the cellular level.
CNS Peptide Receptor Studies
Research has examined GLP-1R expression in central nervous system regions including hypothalamus, brainstem, and areas of reward circuitry.
View semaglutide publications on PubMed →

Sequence Labs Supply

Available Sizes, Testing & COA

Sequence Labs offers research-grade semaglutide in five lyophilized vial sizes. Every batch undergoes independent third-party testing through Krause Analytical in Austin, TX, with batch-specific COAs publicly accessible and verifiable via Finnrick Pulse.

Size Price Form COA Stock
5 mg $43.99 Lyophilized vial ✓ Batch COA In Stock
10 mg $70.99 Lyophilized vial ✓ Batch COA In Stock
15 mg $97.99 Lyophilized vial ✓ Batch COA In Stock
20 mg $128.99 Lyophilized vial ✓ Batch COA In Stock
30 mg $148.99 Lyophilized vial ✓ Batch COA In Stock
HPLC
Identity & Purity
MS
Mass Spec Verified
≥99%
Verified Purity
3rd Party
Krause Analytical
PA-C
Catalog Review

Wholesale available. Research institutions, laboratories, and qualified researchers can apply for tiered pricing — typically 18–32% below retail with no monthly commitment. View wholesale terms →

Laboratory Handling

Receiving, Storage & COA

Semaglutide ships as a sealed lyophilized research vial. Receiving, inventory, and any subsequent laboratory preparation follow your institution’s protocols and the batch Certificate of Analysis. Sequence Labs does not publish reconstitution recipes, solvent volumes, or administration how-to.

  1. Inspect the sealed vial. Confirm the crimp is intact and the lyophilized material appears as a white to off-white powder or cake consistent with a sealed research vial.
  2. Match the batch COA. Verify the lot number against the Krause Analytical Certificate of Analysis before releasing the vial into laboratory inventory.
  3. Store sealed. Keep lyophilized vials protected from light and moisture. Refrigerated storage is the usual default unless the COA or your SOP specifies otherwise.
  4. Follow institutional SOP. Solvent choice, volumes, and in-use handling are determined by the qualified investigator — not by Sequence Labs.

For research use only. All handling must comply with applicable institutional, state, and federal regulations governing research materials. Sequence Labs semaglutide is not a medicine and is not for human use.

Frequently Asked Questions

Semaglutide Research FAQ

No. Sequence Labs semaglutide is a research-grade synthetic GLP-1 receptor agonist analog supplied exclusively for in vitro and preclinical laboratory research. It is not FDA-approved, not formulated for human use, and is not interchangeable with any marketed medicine. It is intended only for qualified researchers and laboratories, not for administration to any person.
Sequence Labs offers semaglutide research compound in five vial sizes: 5mg ($43.99), 10mg ($70.99), 15mg ($97.99), 20mg ($128.99), and 30mg ($148.99). All sizes are lyophilized and supplied with batch-specific COA documentation from Krause Analytical. Wholesale pricing is available for laboratories and research institutions.
Every batch of Sequence Labs semaglutide is independently tested by Krause Analytical (Austin, TX) — a third-party laboratory — using both HPLC and mass spectrometry for identity, purity, and potency verification. Batch-specific Certificates of Analysis (COAs) are publicly accessible and verifiable via the Finnrick Pulse platform. The full catalog is also reviewed by a licensed PA-C for research integrity.
Yes. Research institutions, laboratories, and qualified researchers can access tiered wholesale pricing through Sequence Labs' gated portal. Tiered discounts range from approximately 18% to 32% below retail with no monthly commitment. Contact Team@SequenceLabs.Health or visit the wholesale page to apply.
The glucagon-like peptide-1 (GLP-1) receptor is a G protein-coupled receptor expressed in pancreatic beta cells, the central nervous system, the gastrointestinal tract, and other tissues. It plays a critical role in incretin signaling pathways. Semaglutide is a synthetic GLP-1 receptor agonist analog modified with a C18 fatty diacid chain to extend its plasma half-life versus native GLP-1. Research interest in semaglutide centers on GLP-1 receptor binding mechanisms, pancreatic beta-cell function, gastric motility regulation, and CNS peptide receptor studies — making it one of the most-studied incretin analogs in peer-reviewed literature, with hundreds of indexed publications on PubMed.

Ready to Order?

Research-grade semaglutide, verified and in stock

Five sizes, batch COA from Krause Analytical, reviewed by reviewed by Sabrina Runbeck, PA-C. Order direct or apply for wholesale pricing.

◆ Apply for Wholesale Access